Bharat Biotech

Bharat Biotech defends higher price for COVAXIN in private market

COVID-19 Vaccine: Bharat Biotech reduces price of COVAXIN for state from Rs 600 to Rs 400 per dose

The maker of the COVAXIN, Bharat Biotech had said that it is deeply concerned with the critical pandemic circumstances that India is facing at this time.

Bharat Biotech claims vaccine effective against new UK COVID strain

Bharat Biotech’s nasal vaccine likely to be ‘game-changer’ to end COVID-19

Individuals cannot choose COVID-19 vaccine they prefer, says Health Ministry

India to begin COVID-19 vaccination drive from January 16, ‘A landmark step’ tweets PM Modi

Bharat Biotech and Serum Institute of India will work together to eliminate Coronavirus

Private clinics of Brazil sign deal with India to get alternative COVID-19 vaccine

India likely to deliver 24 million free COVID-19 vaccine doses to Kenya

AstraZeneca likely to get approval from India for emergency use by next week

Bharat Biotech issues clarification post Haryana Home Minister Anil Vij testing positive

Government planning to procure Oxford-AstraZeneca vaccine (COVID) on half the price from MRP

Bharat Biotech’s Covaxin will be 60% effective, tentatively to launch in September 2021

Union Health Minister Harsh Vadhan assures COVID-19 vaccine will be ready in next three-four months

Bharat Biotech announces partnership with Washington University School to produce intranasal COVID-19 Vaccine

The vaccine is peculiar as it will be procured via nose, the initial infected area. Researchers claim the nasal route for vaccination has often seen a stronger immune response.